Showing 5,541 - 5,560 results of 9,157 for search 'significantly ((((((step decrease) OR (we decrease))) OR (teer decrease))) OR (observed decrease))', query time: 0.63s Refine Results
  1. 5541

    Addressing the Gap in Oncologist Training by Skylar Gay (20696057)

    Published 2025
    “…</p><p dir="ltr"><b>Results</b>: The algorithms successfully created radiotherapy dose distributions with decreased organs-at-risk sparing, decreased target conformality, and increased hotspots that were statistically significant (p<0.05) when assessed by dose-volume histogram metrics. …”
  2. 5542

    Measurements per sample and cycle. by David Nora (10098723)

    Published 2025
    “…A decrease in tool efficiency during use may have constrained daily activities, necessitating technological adaptations. …”
  3. 5543

    Detailed view of the SMARTTESTER® device. by David Nora (10098723)

    Published 2025
    “…A decrease in tool efficiency during use may have constrained daily activities, necessitating technological adaptations. …”
  4. 5544

    Imaging equipment, acquisition settings. by David Nora (10098723)

    Published 2025
    “…A decrease in tool efficiency during use may have constrained daily activities, necessitating technological adaptations. …”
  5. 5545

    Table 1_Association between telomere length and idiopathic normal pressure hydrocephalus: a Mendelian randomization study.docx by Feng Yang (132135)

    Published 2024
    “…</p>Results<p>Genetically determined longer telomere length was significantly associated with decreased risk of iNPH (OR = 0.44, 95% CI 0.24–0.80; p = 0.008). …”
  6. 5546

    Table 1_Anti-Müllerian hormone, sex steroids, and metabolic profile in cord blood of pregnancies with type 2 diabetes and gestational diabetes.docx by Claudio Villarroel (808234)

    Published 2025
    “…No significant correlations were observed between maternal and AMH, insulin, IGF-1, and androgen VCB levels.…”
  7. 5547

    Table 2_Anti-Müllerian hormone, sex steroids, and metabolic profile in cord blood of pregnancies with type 2 diabetes and gestational diabetes.docx by Claudio Villarroel (808234)

    Published 2025
    “…No significant correlations were observed between maternal and AMH, insulin, IGF-1, and androgen VCB levels.…”
  8. 5548

    DataSheet1_Risk of bone fracture by using dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors in patients wit... by Mohamed E. A. Mostafa (19834779)

    Published 2024
    “…The risk of fracture was identified with the follow-up duration for each class. We found a significant decrease in the fracture risk by about 87% associated with patients who used SGLT2 inhibitors in combination with other glucose-lowering medications, followed by SGLT2 inhibitors alone by about 67%, then GLP-1 receptor agonists by about 60%, and at last DPP-4 inhibitors by about 55%.…”
  9. 5549

    DataSheet2_Risk of bone fracture by using dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors in patients wit... by Mohamed E. A. Mostafa (19834779)

    Published 2024
    “…The risk of fracture was identified with the follow-up duration for each class. We found a significant decrease in the fracture risk by about 87% associated with patients who used SGLT2 inhibitors in combination with other glucose-lowering medications, followed by SGLT2 inhibitors alone by about 67%, then GLP-1 receptor agonists by about 60%, and at last DPP-4 inhibitors by about 55%.…”
  10. 5550

    DataSheet3_Risk of bone fracture by using dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors in patients wit... by Mohamed E. A. Mostafa (19834779)

    Published 2024
    “…The risk of fracture was identified with the follow-up duration for each class. We found a significant decrease in the fracture risk by about 87% associated with patients who used SGLT2 inhibitors in combination with other glucose-lowering medications, followed by SGLT2 inhibitors alone by about 67%, then GLP-1 receptor agonists by about 60%, and at last DPP-4 inhibitors by about 55%.…”
  11. 5551

    Cardiovascular safety of Janus kinase inhibitors in inflammatory bowel disease: a systematic review and network meta-analysis by Huibin Yang (10486204)

    Published 2025
    “…</p> <p>Although a trend of increased cardiovascular risks was found considering dose, no significantly increased cardiovascular risk was associated with JAKinibs in IBD patients, and Deucravacitinib significantly decreased the risks of VTE and CVE.…”
  12. 5552

    Ydj1 acetylation alters interactions with client proteins. by Siddhi Omkar (12413434)

    Published 2024
    “…Interactors are colored according to change in interaction as follows: green (significant increase), red (significant decrease), or purple (no significant change) 6KQ/6KR. …”
  13. 5553

    Prolonged sitting time and all-cause mortality: the mediating and predictive role of kidney function markers by Li Wang (15202)

    Published 2025
    “…</p> <p>A total of 9,707 adults were included in the analysis. There was a significant increase in the levels of blood urea nitrogen (BUN), creatinine, uric acid, osmolality, and UACR with extended daily sitting time, while eGFR significantly decreased. …”
  14. 5554

    Supplementary Material for: Analysis of Brain Functional Connectivity in Patients with Delayed Encephalopathy After Carbon Monoxide Poisoning Based on Functional Near-Infrared Spec... by figshare admin karger (2628495)

    Published 2025
    “…Compared with the control group, the brain network of DEACMP patients showed heterogeneity from left PC to right PC; Left PC~Left PMC; Left PC~right PMC; Left PC~Left DLPFC ,etc.The functional connectivity strength between the left PC and the right DLPFC area has significantly decreased. All these differences were statistically significant (P<0.05, FDR adjusted). …”
  15. 5555

    Image 1_Comparison between the protective effect of the orally administered atorvastatin and safflower (Carthamus tinctorius) in hypercholesterolemic male rats.pdf by Haddad A. El Rabey (22248019)

    Published 2025
    “…Atorvastatin treatment in G4 demonstrated superior efficacy compared to safflower extract in addressing hypercholesterolemia, despite the latter’s significant hypolipidemic effect observed in G3.</p>…”
  16. 5556

    Table 1_Comparison between the protective effect of the orally administered atorvastatin and safflower (Carthamus tinctorius) in hypercholesterolemic male rats.docx by Haddad A. El Rabey (22248019)

    Published 2025
    “…Atorvastatin treatment in G4 demonstrated superior efficacy compared to safflower extract in addressing hypercholesterolemia, despite the latter’s significant hypolipidemic effect observed in G3.</p>…”
  17. 5557

    Table 1_Safety and efficacy of canine recombinant IL-15 in mammary gland tumors.docx by Min-Hee Kang (811734)

    Published 2025
    “…Clinical monitoring included physiological assessments, blood tests, and owner-reported quality of life (QoL) questionnaires. No significant adverse changes were observed in hematological, biochemical, or physiological parameters. …”
  18. 5558

    Data Sheet 1_Preoperative geriatric nutritional risk index as a predictor of postoperative delirium in revision arthroplasty: a 10-year retrospective cohort study.docx by Xuming Chen (2404711)

    Published 2025
    “…</p>Conclusion<p>A significant association was observed between preoperative GNRI and POD in patients undergoing hip or knee revision arthroplasty. …”
  19. 5559

    Table 3_Comparison between the protective effect of the orally administered atorvastatin and safflower (Carthamus tinctorius) in hypercholesterolemic male rats.docx by Haddad A. El Rabey (22248019)

    Published 2025
    “…Atorvastatin treatment in G4 demonstrated superior efficacy compared to safflower extract in addressing hypercholesterolemia, despite the latter’s significant hypolipidemic effect observed in G3.</p>…”
  20. 5560

    Enamel matrix derivative in the treatment of tooth replantation: from a biological basis to clinical application by Yao Lin (1622536)

    Published 2024
    “…Our pooling results indicated that EMD did not provide a numerical advantage for restoring normal PDL healing in replanted teeth (RR=0.38, <i>P</i>=0.161). A significantly lower extraction risk was observed in EMD-treated group than non-EMD-treated group (RR=0.47, <i>P</i>=0.001). …”